Compound information
- Natural Products
- ZC161178
- Molecular Formula
- C14H20N4O4
- Molecular Weight
- 308.14845512 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C14H20N4O4/c15-13(16)17-8-4-7-11(12(19)20)18-14(21)22-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,18,21)(H,19,20)(H4,15,16,17)/t11-/m0/s1
- InChI Key
- SJSSFUMSAFMFNM-NSHDSACASA-N
- SMILES
- N=C(N)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000001540612
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 137.53 Å2 | LogP | -0.221 |
LogS | -2.642 | LogD | -0.485 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.176 |
HIA | 0.001 | F20 % | 0.477 |
F30 % | 0.001 | Caco-2 | -6.594 |
MDCK | -5.758 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.84 | PPB | 53.561 |
VD | 0.36 | Fu | 0.182 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.695 |
CYP2A6 substrate | 0.392 | CYP2B6 substrate | 0.508 |
CYP2C19 inhibitor | 0.121 | CYP2C19 substrate | 0.821 |
CYP2C8 substrate | 0.683 | CYP2C9 inhibitor | 0.179 |
CYP2C9 substrate | 0.589 | CYP2D6 inhibitor | 0.124 |
CYP2D6 substrate | 0.655 | CYP2E1 substrate | 0.235 |
CYP3A4 inhibitor | 0.014 | CYP3A4 substrate | 0.63 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.636 | CL | 4.057 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.667 | Hepatotoxicity | 0.063 |
Mutagenicity | 0.019 | Rat Oral Acute Toxicity | 0.035 |
FDAMDD | 0.065 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.103 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.375 | IGC50 | 1.764 |
LC50FM | 3.342 | LC50DM | 4.265 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.266 | NR-AR-LBD | 0.28 |
NR-AhR | 0.003 | NR-Aromatase | 0.025 |
NR-ER | 0.329 | NR-ER-LBD | 0.345 |
NR-PPAR-gamma | 0.485 | SR-ARE | 0.077 |
SR-ATAD5 | 0.323 | SR-HSE | 0.105 |
SR-MMP | 0.009 | SR-p53 | 0.019 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.